These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 36609038

  • 1. Clinical Impact of Drug-Coated Balloon-Based Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease.
    Shin ES, Jun EJ, Kim S, Kim B, Kim TH, Sohn CB, Her AY, Park Y, Cho JR, Jeong YH, Choi BJ.
    JACC Cardiovasc Interv; 2023 Feb 13; 16(3):292-299. PubMed ID: 36609038
    [Abstract] [Full Text] [Related]

  • 2. Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease.
    Her AY, Shin ES, Kim S, Kim B, Kim TH, Sohn CB, Choi BJ, Park Y, Cho JR, Jeong YH.
    Cardiovasc Diabetol; 2023 May 20; 22(1):120. PubMed ID: 37210516
    [Abstract] [Full Text] [Related]

  • 3. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
    Kang IS, Shehata I, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.
    Heart Vessels; 2016 Sep 20; 31(9):1405-11. PubMed ID: 26337620
    [Abstract] [Full Text] [Related]

  • 4. Long-term efficacy of drug-coated balloon-based treatment for de novo left anterior descending artery disease.
    Kang DO, Kim S, Kim B, Her AY, Shin ES.
    Sci Rep; 2024 Oct 16; 14(1):24260. PubMed ID: 39414874
    [Abstract] [Full Text] [Related]

  • 5. Drug-Coated Balloon Angioplasty for De Novo Lesions on the Left Anterior Descending Artery.
    Gitto M, Sticchi A, Chiarito M, Novelli L, Leone PP, Mincione G, Oliva A, Condello F, Rossi ML, Regazzoli D, Gasparini G, Cozzi O, Stefanini GG, Condorelli G, Reimers B, Mangieri A, Colombo A.
    Circ Cardiovasc Interv; 2023 Dec 16; 16(12):e013232. PubMed ID: 37874646
    [Abstract] [Full Text] [Related]

  • 6. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
    Ribichini F, Romano M, Rosiello R, La Vecchia L, Cabianca E, Caramanno G, Milazzo D, Loschiavo P, Rigattieri S, Musarò S, Pironi B, Fiscella A, Amico F, Indolfi C, Spaccarotella C, Bartorelli A, Trabattoni D, Della Rovere F, Rolandi A, Beqaraj F, Belli R, Sangiorgio P, Villani R, Berni A, Sheiban I, Lopera Quijada MJ, Cappi B, Ribaldi L, Vassanelli C, EXECUTIVE Trial Investigators.
    JACC Cardiovasc Interv; 2013 Oct 16; 6(10):1012-22. PubMed ID: 24055444
    [Abstract] [Full Text] [Related]

  • 7. Long-term clinical safety and efficacy of drug-coated balloon in the treatment of in-stent restenosis: A meta-analysis and systematic review.
    Xi Y, Chen J, Bi Y, Xie S, Liao T, Zhang Y, Kislauskis E, Wu T, Laham R, Xiao J.
    Catheter Cardiovasc Interv; 2020 Aug 16; 96(2):E129-E141. PubMed ID: 31714010
    [Abstract] [Full Text] [Related]

  • 8. A HYbrid APproach Evaluating a DRug-Coated Balloon in Combination With a New-Generation Drug-Eluting Stent in the Treatment of De Novo Diffuse Coronary Artery Disease: The HYPER Pilot Study.
    Ielasi A, Buono A, Pellicano M, Tedeschi D, Loffi M, Donahue M, Regazzoli D, De Angelis G, Danzi G, Reimers B, Tespili M.
    Cardiovasc Revasc Med; 2021 Jul 16; 28():14-19. PubMed ID: 32933874
    [Abstract] [Full Text] [Related]

  • 9. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
    Zhang DP, Wang LF, Liu Y, Li KB, Xu L, Li WM, Ni ZH, Xia K, Zhang ZY, Yang XC.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul 24; 48(7):600-607. PubMed ID: 32842271
    [Abstract] [Full Text] [Related]

  • 10. A Non-inferiority, Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon Versus New-Generation Drug-Eluting Stents on Angiographic Outcomes for Coronary De Novo Lesions.
    Yu X, Wang X, Ji F, Zhang W, Yang C, Xu F, Wang F.
    Cardiovasc Drugs Ther; 2022 Aug 24; 36(4):655-664. PubMed ID: 33713211
    [Abstract] [Full Text] [Related]

  • 11. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.
    Costopoulos C, Latib A, Naganuma T, Sticchi A, Figini F, Basavarajaiah S, Carlino M, Chieffo A, Montorfano M, Naim C, Kawaguchi M, Giannini F, Colombo A.
    JACC Cardiovasc Interv; 2013 Nov 24; 6(11):1153-9. PubMed ID: 24262615
    [Abstract] [Full Text] [Related]

  • 12. Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis.
    de la Torre Hernández JM, Garcia Camarero T, Lozano Ruiz-Poveda F, Urbano-Carrillo CA, Sánchez Pérez I, Cano-García M, Saez R, Andrés Morist A, Molina E, Pinar E, Torres A, Lezcano EJ, Gutierrez H, Arnold RJ, Zueco J.
    Cardiovasc Revasc Med; 2020 Apr 24; 21(4):508-513. PubMed ID: 31401071
    [Abstract] [Full Text] [Related]

  • 13. Drug-coated balloon strategy following orbital atherectomy for calcified coronary artery compared with drug-eluting stent: One-year outcomes and optical coherence tomography assessment.
    Mitsui K, Lee T, Miyazaki R, Hara N, Nagamine S, Nakamura T, Terui M, Okata S, Nagase M, Nitta G, Watanabe K, Kaneko M, Nagata Y, Nozato T, Ashikaga T.
    Catheter Cardiovasc Interv; 2023 Jul 24; 102(1):11-17. PubMed ID: 37210618
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and Prediction Model Construction of Drug-Coated Balloon Combined with Cutting Balloon Angioplasty in the Treatment of Drug-Eluting Stent In-Stent Restenosis.
    Wu H, Yu T, Fan T, Liao W.
    Comput Math Methods Med; 2022 Jul 24; 2022():9832622. PubMed ID: 36238492
    [Abstract] [Full Text] [Related]

  • 15. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.
    Kokkinidis DG, Prouse AF, Avner SJ, Lee JM, Waldo SW, Armstrong EJ.
    Catheter Cardiovasc Interv; 2018 Aug 01; 92(2):285-299. PubMed ID: 29024274
    [Abstract] [Full Text] [Related]

  • 16. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.
    Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B.
    EuroIntervention; 2015 Dec 01; 11(8):926-34. PubMed ID: 25169589
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of drug-coated balloon angioplasty in early versus late occurring drug-eluting stent restenosis: A pooled analysis from the randomized ISAR DESIRE 3 and DESIRE 4 trials.
    Koch T, Cassese S, Xhepa E, Mayer K, Tölg R, Hoppmann P, Laugwitz KL, Byrne RA, Kastrati A, Kufner S.
    Catheter Cardiovasc Interv; 2020 Nov 01; 96(5):1008-1015. PubMed ID: 31789486
    [Abstract] [Full Text] [Related]

  • 18. A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions.
    Kook H, Joo HJ, Park JH, Hong SJ, Yu CW, Lim DS.
    BMC Cardiovasc Disord; 2020 Feb 18; 20(1):83. PubMed ID: 32070287
    [Abstract] [Full Text] [Related]

  • 19. Recurrent Revascularization at 10 Years After Percutaneous Treatment of Drug-Eluting Stent Restenosis.
    Koch T, Lenz T, Rheude T, Cassese S, Kazazi M, Xhepa E, Kessler T, Wiebe J, Ferenc M, Laugwitz KL, Joner M, Schunkert H, Kastrati A, Kufner S.
    JACC Cardiovasc Interv; 2024 Jan 08; 17(1):1-13. PubMed ID: 37902151
    [Abstract] [Full Text] [Related]

  • 20. Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients.
    Funayama N, Muratsubaki S, Ito R, Tobisawa T, Konishi T.
    Heart Vessels; 2023 Mar 08; 38(3):300-308. PubMed ID: 36045267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.